简介：摘要目的分析内科胸腔镜联合冷冻治疗结核性包裹性胸腔积液患者的护理要点。方法回顾性分析67例经内科胸腔镜联合冷冻治疗结核性包裹性胸腔积液患者的临床资料，分析患者围手术期护理效果，总结患者的围手术期护理要点。结果67例患者有效治疗，有效率为97.0%，3例患者经二次治疗后好转，2例病程长，胸腔内纤维板厚，剥离不佳转外科治疗。术后未出现感染。结论有必要加强内科胸腔镜联合冷冻治疗结核性包裹性胸腔积液患者的围手术期护理，提高预后质量。

简介：摘要：小学数学教学中，趣味性教学可以激发学生学习兴趣，培养自主学习能力；创设轻松学习环境，调动学生积极性；营造和谐学习氛围，增强学生学习意识。从而帮助学生更好地学习。

简介：摘要白内障是老年人主要的致盲的原因，老年性白内障常发生在50岁以上的患者，晶状体是一个透明的双凸透镜，正常情况下外界物体经过它的作用成像于视网膜，晶状体一旦变性混浊以至于影响视力，即为白内障，老年性白内障常以单眼先后发生，也可双眼同时发生。同时还会伴有如高血压、糖尿病等老年人常患有的疾病，因此做好老年性白内障患者的术中配合护理是手术成功的关键。

简介：摘要目的观察穴位埋线治疗单纯性肥胖的临床疗效，为临床上采用穴位埋线治疗单纯性肥胖提供依据。方法选取２０１３年１月至２０１４年５月至我院就诊的单纯性肥胖的女性６０例，采用随机数字表法将患者分为治疗组和对照组，治疗组３２例采用穴位埋线疗法治疗，对照组２８例采用电针治疗，比较两组临床疗效。结果治疗组总有效率９３．８％，对照组总有效率８５．７％，两组比较差异具有统计学意义（Ｐ＜０．０５）。结论穴位埋线和电针治疗均能明显降低单纯性肥胖患者的体重，但穴位埋线疗法疗效优于电针治疗，是一种简便、持久、省时、经济的治疗方法。

简介：　　 [摘要 ] 目的 探究肾综合征出血热连续性肾脏替代治疗及肝素抗凝的临床应用情况。方法 选取在该院 2017年 1月— 2019年 8月进行诊治的肾综合征出血热患者 60例进行回顾性分析。 结果 危重型患者重叠期初始连续性肾脏替代治疗的有效率是 50.0%，重型为 9.0%，危重型患者连续性肾脏替代治疗效果以及重叠期开始连续性肾脏替代治疗明显高于重型。结论 连续性肾脏替代治疗需结合患者特点合理选择是否使用肝素抗凝。  　　 [关键词 ] 肾综合征出血热；连续性肾脏替代治疗  [Abstract] Objective To explore the clinical application of continuous renal replacement therapy and heparin anticoagulation for hemorrhagic fever with renal syndrome. Methods 60 cases of HFRS diagnosed and treated in our hospital from January 2017 to August 2019 were analyzed retrospectively. Results the effective rate of continuous renal replacement therapy was 50.0% and 9.0% in severe patients. The effect of continuous renal replacement therapy and the beginning of continuous renal replacement therapy in severe patients were significantly higher than that in severe patients. Conclusion continuous renal replacement therapy should be combined with the characteristics of patients to choose whether to use heparin anticoagulation.

简介：　　【摘要】 目的：探讨腺苷蛋氨酸联合糖皮质激素在药物性胆汁淤积性肝病（ CLD）中的临床疗效与可行性。方法：选取 2017年 7月 -2019年 8月笔者所在医院收治的 98例药物性 CLD患者，随机分为观察组与对照组，各 49例，对照组仅给予综合保肝治疗，观察组在此基础上应用腺苷蛋氨酸 +糖皮质激素，观察两组治疗前后肝功能指标，评估临床疗效与用药安全性。结果：两组患者治疗后血清总胆红素（ TBIL）、谷丙转氨酸（ ALT）、谷丙转氨酶（ ALP）、谷氨酰转肽酶（ γ-GT）各项肝功能指标均得到明显纠正，但观察组下降幅度明显大于对照组，差异有统计学意义（ P<0.05）；治疗总有效率为 95.9%，明显高于对照组的 81.6%，差异有统计学意义（ P<0.05）；有 3例（ 6.12%）患者出现轻微不良反应，包括血糖轻度升高、低血钾、电解质紊乱各 1例，对症治疗后症状消失，未出现感染、白细胞升高、上消化道出血等严重不良反应，对照组有 4例（ 8.16%）患者出现轻微不良反应，两组不良反应发生率相似，差异无统计学意义（ P>0.05）。结论：腺苷蛋氨酸联合糖皮质激素是一种安全、有效的用药方案，在保证治疗效果的同时不会增加不良反应，值得在药物性胆汁淤积性肝病中推广使用。  　　【关键词】 药物性胆汁淤积性肝病； 腺苷蛋氨酸； 糖皮质激素； 临床疗效  [Abstract] Objective: To investigate the clinical efficacy and feasibility of adenosylmethionine combined with glucocorticoid in patients with drug-induced cholestatic liver disease (CLD). Methods: from July 2017 to August 2019, 98 patients with drug-induced CLD were randomly divided into the observation group and the control group, with 49 cases in each group. The control group was only given comprehensive liver protection treatment. On this basis, the observation group was given adenosylmethionine + glucocorticoid to observe the liver function indexes before and after treatment, and to evaluate the clinical efficacy and drug safety. Results: after treatment, the liver function indexes of TBIL, alt, ALP and γ - GT in the two groups were significantly corrected, but the decrease of the observation group was significantly greater than that of the control group (P < 0.05); the total effective rate of the treatment was 95.9%, significantly higher than 81.6% in the control group, and the difference was statistically significant (P < 0.05) Statistical significance (P < 0.05); 3 patients (6.12%) had slight adverse reactions, including slight increase in blood glucose, hypokalemia, electrolyte disorder, 1 case respectively. After symptomatic treatment, symptoms disappeared, no serious adverse reactions such as infection, leukocytosis, upper gastrointestinal hemorrhage, 4 patients (8.16%) in the control group had slight adverse reactions, and the incidence of adverse reactions in the two groups was similar and poor The difference was not statistically significant (P > 0.05). Conclusion: adenosylmethionine combined with glucocorticoid is a safe and effective drug regimen, which can ensure the therapeutic effect without increasing adverse reactions. It is worth popularizing in drug-induced cholestatic liver disease.